Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 4
2007 1
2008 1
2009 2
2012 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
[Prevention of infections and thromboses after splenectomy or because of functional loss of the spleen].
Engelhardt M, Haas PS, Theilacker C, Eber SW, Schmugge M, Kern WV, Heimpel H. Engelhardt M, et al. Among authors: haas ps. Dtsch Med Wochenschr. 2009 Apr;134(17):897-902. doi: 10.1055/s-0029-1220231. Epub 2009 Mar 31. Dtsch Med Wochenschr. 2009. PMID: 19337961 Review. German.
NT-pro-BNP: not the prognostic all-rounder in elderly patients undergoing allogeneic stem cell transplantation.
Haas PS, Ihorst G, Schnitzler S, Wäsch R, Marks R, Bertz H, Mertelsmann R, Finke J, Deschler B. Haas PS, et al. Ann Hematol. 2012 Dec;91(12):1929-35. doi: 10.1007/s00277-012-1529-8. Epub 2012 Jul 31. Ann Hematol. 2012. PMID: 22847152
The role of X-inactivation in the gender bias of patients with acquired alpha-thalassaemia and myelodysplastic syndrome (ATMDS).
Haas PS, Roy NB, Gibbons RJ, Deville MA, Fisher C, Schwabe M, Bissé E, van Dorsselaer A, Higgs DR, Lübbert M. Haas PS, et al. Br J Haematol. 2009 Feb;144(4):538-45. doi: 10.1111/j.1365-2141.2008.07505.x. Br J Haematol. 2009. PMID: 19055664
State of the art therapy in multiple myeloma and future perspectives.
Denz U, Haas PS, Wäsch R, Einsele H, Engelhardt M. Denz U, et al. Among authors: haas ps. Eur J Cancer. 2006 Jul;42(11):1591-600. doi: 10.1016/j.ejca.2005.11.040. Epub 2006 Jul 3. Eur J Cancer. 2006. PMID: 16815703 Review.
Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.
Haas PS, Bauchmüller K, Kühnemund A, Finke J, Ihorst G, Engelhardt M. Haas PS, et al. Ann Hematol. 2006 Mar;85(3):191-3. doi: 10.1007/s00277-005-0040-x. Epub 2005 Dec 20. Ann Hematol. 2006. PMID: 16365747 No abstract available.
Quantification of outpatient management and hospitalization of patients with high-risk myelodysplastic syndrome treated with low-dose decitabine.
Pitako JA, Haas PS, Van den Bosch J, Müller-Berndorff H, Kündgen A, Germing U, Wijermans PW, Lübbert M. Pitako JA, et al. Among authors: haas ps. Ann Hematol. 2005 Dec;84 Suppl 1:25-31. doi: 10.1007/s00277-005-0007-y. Ann Hematol. 2005. PMID: 16292666
Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
Müller-Berndorff H, Haas PS, Kunzmann R, Schulte-Mönting J, Lübbert M. Müller-Berndorff H, et al. Among authors: haas ps. Ann Hematol. 2006 Aug;85(8):502-13. doi: 10.1007/s00277-005-0030-z. Epub 2006 May 20. Ann Hematol. 2006. PMID: 16715299
Thalidomide in consecutive multiple myeloma patients: single-center analysis on practical aspects, efficacy, side effects and prognostic factors with lower thalidomide doses.
Haas PS, Denz U, Ihorst G, Engelhardt M. Haas PS, et al. Eur J Haematol. 2008 Apr;80(4):303-9. doi: 10.1111/j.1600-0609.2007.01022.x. Epub 2007 Dec 21. Eur J Haematol. 2008. PMID: 18182082
Treatment of myelodysplastic syndrome with a DNA methyltransferase inhibitor: lack of evidence for induction of chromosomal instability.
Haas PS, Wijermans P, Verhoef G, Lübbert M. Haas PS, et al. Leuk Res. 2006 Mar;30(3):338-42. doi: 10.1016/j.leukres.2005.07.014. Epub 2005 Sep 12. Leuk Res. 2006. PMID: 16162357 Clinical Trial.